Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Ligand. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel oxaspiro diphosphine ligand synthesis enables >99% ee hydrogenation. Reliable supplier for high-purity chiral intermediates.
Patent CN112824421A reveals a robust chiral ligand synthesis route offering high enantioselectivity and TON up to 10000 for pharmaceutical manufacturing.
Patent CN110845547A details novel Pd-catalyzed asymmetric alkylation. Offers high ee values and mild conditions for indole derivatives manufacturing.
Patent CN110878104A reveals a safer two-step route for chiral phosphine ligands. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing with scalable processes.
Patent CN112538033A details a Pd-catalyzed kinetic resolution method yielding high-purity chiral cyclophanes with superior enantioselectivity and scalability.
Patent CN105859800B details a high-yield synthesis of chiral ferrocene P,P ligands. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN102781948A details stable P-chiral aminodiphosphine ligands enabling high-ee asymmetric hydrogenation for cost-effective chiral pharmaceutical intermediates manufacturing.
Novel preparation of cis-2-(diphenylphosphino)-1-cyclohexanecarboxylic acid via asymmetric addition. Enhances catalytic efficiency and reduces manufacturing costs for high-purity intermediates.
Patent CN102984945B details a high-yield asymmetric hydrogenation process for Ramipril and Perindopril intermediates, offering significant cost and purity advantages for pharmaceutical supply chains.
Patent CN113292598A discloses a Rh(III)-catalyzed enantioselective synthesis of axial chiral biaryl compounds with P-stereocenters, offering significant supply chain advantages.
Novel iridium-catalyzed C-H bond boronation method offers high selectivity and yield for pharmaceutical intermediate manufacturing without strong acids.
Discover the novel synthesis of chiral binaphthyl-aza ligands from patent CN112142638A. Achieve high enantioselectivity with scalable, cost-effective manufacturing processes.
Patent CN115385948A discloses silicon-centered spiro-bisoxazoline ligands enabling high-yield asymmetric carbene insertion. Ideal for reliable pharmaceutical intermediate supplier needs.
Patent CN109293700B discloses a novel chiral ligand enabling ultra-low nickel loading for enantioselective cyclization, offering significant cost and efficiency advantages.
Patent CN112047856B details efficient Rh-catalyzed asymmetric hydrogenation for high-purity chiral alpha-amidoaldehydes, offering significant cost reduction and supply chain stability for pharma manufacturing.
Patent CN115490730A reveals a novel synthesis for chiral BIDIME Se/S ligands using modified diatomite purification, offering high yields and scalable production for pharmaceutical intermediates.
Patent CN102532225A details a novel methyl glucoside-derived ligand enabling high-yield asymmetric conjugate additions, offering cost-effective solutions for pharmaceutical intermediate manufacturing.
Patent CN120208942A reveals a novel synthesis route for C2 symmetric ligands. This method offers significant cost reduction and supply chain reliability for high-purity pharmaceutical intermediates.
Patent CN103193830A reveals a flexible route for chiral ferrocene phosphine ligands, offering cost reduction in pharmaceutical intermediate manufacturing and reliable supply.
Patent CN104892472A details a novel bis-chiral sulfoxide-alkene ligand synthesis enabling high-efficiency rhodium-catalyzed asymmetric allylation for pharmaceutical intermediate manufacturing.